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ABSTRACT: The regiospecific halogen exchange reactions of various easily accessible meso-
bromoporphyrins to obtain meso-iodoporphyrins, using η1-palladioporphyrins as intermediates, have 
been investigated. This one-pot methodology allows the isolation of meso-iodoporphyrins in excellent 
yields with short reaction times. Similarly meso-(2-bromoethenyl)porphyrins can be converted to their 
iodoethenyl analogues. These iodoporphyrins show great potential as starting materials for various 
palladium catalysed reactions. The X-ray crystal structure of 5-iodo-10,20-diphenylporphyrin has been 
determined. 
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INTRODUCTION 
In the past decade the palladium catalysed formation of new C-C and C-X bonds has emerged as a versatile method 
for the meso-functionalisation of various porphyrins. Due to the selectivity and mild reaction conditions a variety of 
otherwise challenging reactions can now be accomplished with relative ease, leading to novel substitution patterns and 
interesting multiporphyrin arrays [1]. The intermediates of these reactions are meso-η1-palladioporphyrins, which were 
first isolated in 1998 [2]. Since then we have reported numerous examples of these novel organopalladium porphyrins 
and their more robust platinum(II) analogues [3]. Bromoporphyrins have been the preferred starting materials for 
palladium catalysed reactions, as the NBS bromination of unsubstituted porphyrins can be accomplished with short 
reaction times [4]. In the case of porphyrin substrates with just one unsubstituted meso-position, mono-
bromoporphyrins can be isolated with almost quantitative yield [3b], while with a slight excess of NBS, porphyrins 
with two vacant meso-positions afford the 5,15-dibromoporphyrins quantitatively [4]. The lack of selectivity of the 
NBS bromination of porphyrins with two vacant meso-positions has been overcome recently by our group with the aid 
of organopalladium porphyrins [5]. 
Iodide on the other hand is known to be a better leaving group than bromide in transition metal catalysed reactions  
[6]. The oxidative addition of the zerovalent palladium fragment, often the first step of the catalytic cycle, occurs much 
more readily with iodides than with bromides, leading to faster reactions times, higher yields and selective reactions at 
the iodinated site, if both halogens are present. In some cases the desired substitution reaction cannot be accomplished 
at all, due to the less polarisable C-Br bond [7]. It is therefore no surprise that often iodoporphyrins have to be utilised 
in order to accomplish palladium catalysed substitution reactions. Examples of alkynes [8], organoboranes [8d,8g,9], 
organotins [8l,10], alkenes [8d,8l] and organozincs [11] reacting with meso-iodoporphyrins as starting materials can be 
found in the literature.  
Unfortunately the selective meso-iodination of porphyrins cannot be as rapidly and selectively accomplished as the 
meso-bromination. Only two practical methods for the meso-iodination of porphyrins are described in the literature, 
both with their respective limitations. Boyle and co-workers [8a,8b,8h] introduced a hypervalent I(III) reagent to 
accomplish the iodination of porphyrins, and most other users of iodoporphyrins have used this method. Although 
excellent yields can be achieved, long reaction times of up to 48 hours are required and unselective additional 
iodination in β-positions can occur. The porphyrin cation radical method reported by Osuka’s group [8c] on the other 
hand yields selectively meso-iodinated porphyrins with very short reaction times. Unfortunately lower yields and the 
necessity of zinc porphyrins as starting materials limit this method. 
We were seeking to accomplish the selective meso-iodination of 5,15-diaryl- and 5,10,15-triarylporphyrins with 
short reaction times, in high yields and with the possibility to utilise free-base porphyrins as starting materials. Here we 
wish to report such a methodology using the stoichiometric amounts of organopalladium complexes as intermediates 
for the selective meso-iodination of porphyrins. This method has been extended to the formation of meso-(2-
iodoethenyl)porphyrins, useful starting materials that have previously been prepared only for Ni(II) octaethyl- and 
tetraphenylporphyrin [12]. 
EXPERIMENTAL 
General 
All synthetic reactions involving zerovalent palladium metal reagents were carried out in an atmosphere of high-
purity argon using standard Schlenk techniques [13]. Chemical reagents and ligands were of laboratory reagent (LR) or 
analytical reagent (AR) grade, received from Sigma-Aldrich and used without further purification. Solvents used were 
AR grade where available. Solvents used in palladium catalysed reactions were degassed by freeze/thawing under 
vacuum three times prior to their use. Toluene and diethyl ether were stored over sodium wire. CH2Cl2 and CHCl3 were 
stored over anhydrous sodium carbonate. Tetrahydrofuran (THF) was distilled immediately before use from a dark blue 
sodium/benzophenone solution under an atmosphere of high purity argon. Bromoporphyrins 2 [8h], 5 [3b], 6 [3b], 7 
[3c] and 8 [14], η1-palladioporphyrin 1 [2], ethenylporphyrin 14 [15] and Pd(PPh3)4 [16] were synthesised according to 
the literature. Recrystallisation from two solvents was accomplished by dissolving the product in a minimum amount of 
the first solvent and carefully layering the solution with a tenfold excess of the second solvent. Analytical TLC was 
performed using aluminium backed Merck silica gel 60 F254 plates and column chromatography was carried out using 
silica gel (230-400 mesh) from Qingdao Haiyang Chemical Co. Ltd., Qingdao, China. NMR spectra were recorded on a 
Bruker Avance 400 MHz instrument with CHCl3 as internal standard at 7.26 ppm for 1H spectra and 85% aqueous 
H3PO4 as external standard for proton-decoupled 31P spectra. Quantitative UV/Vis spectra were recorded on a Cary 3 
spectrometer. High accuracy ESI mass spectra were recorded on a Bruker BioApex 47e FTMS fitted with an Analytica 
Electrospray source. Dichloromethane was used as a solvent and the samples were diluted either with 
dichloromethane/methanol or just methanol. The samples were introduced into the source by direct infusion (syringe 
pump) at 60 μL/h with a capillary voltage of 80 V. Sodium iodide clusters were used as internal standard for the 
calibration of the instrument. Laser Desorption/Ionization (LDI) MS analysis was performed with an Applied 
Biosystems Voyager-DE STR BioSpectrometry Workstation. The instrument was operated in positive polarity in 
reflectron mode. Samples were spotted on a stainless steel sample plate and allowed to air dry. Data from 500 laser 
shots (337 nm nitrogen laser) were collected, signal averaged, and processed with the instrument manufacturer's Data 
Explorer software. Isotopic modelling was performed using MassLynx V3.5 Software by Micromass Limited. 
Elemental analyses were carried out by the Microanalytical Service, The University of Queensland. 
Synthesis 
5-Iodo-10,20-diphenylporphyrin (3) from η1-palladioporphyrin (1) 
Palladioporphyrin 1 (20 mg, 0.019 mmol) was dissolved in toluene (6 ml) and a solution of iodine in toluene (5 mg, 
0.020 mmol, 2 ml) was added dropwise to the reaction mixture. After stirring for 10 min at room temperature, the 
solvent was removed under vacuum and the product was purified on a short column packed with silica gel using 
CH2Cl2/hexane/triethylamine (400:200:3) as eluent and recrystallised from CH2Cl2/MeOH to give dark purple crystals 
(10.2 mg, 91%). By changing the eluent to CH2Cl2, the palladium(II) complexes 4 can be isolated. 1H NMR (400 MHz, 
CDCl3, 25° C): ™H, ppm 10.18 (s, 1H, meso-H), 9.76, 9.29, 8.95, 8.92 (d, each 2H, J 4.7 Hz, β-H), 8.22-8.20 (m, 4H, 
o-H), 7.78-7.76 (m, 6H, m,p-H), -3.01 (br s, 2H, NH). UV-vis (CH2Cl2): ⎣max, nm (∑, 103 M-1.cm-1) 417 (317), 513 
(14.9), 546 (5.1), 588 (4.4), 644 (2.2). High-resolution ESI MS: m/z 589.0884 ([C32H21IN4+H]+ requires 589.0889). 
General procedure for the one-pot iodination 
The bromoporphyrin was added to a Schlenk vessel, dried under high vacuum and subsequently the vessel was 
charged with argon. Toluene was added and the solvent was deoxygenated by freeze/thawing three times before heating 
to 105° C. The appropriate amounts of Pd2dba3/PPh3 or freshly prepared Pd(PPh3)4 were added in portions and the 
reaction was monitored by TLC. After the disappearance for the spot representing the haloporphyrin, the mixture was 
cooled to room temperature and diluted with toluene. At this stage the Schlenk vessel was opened to air and the 
appropriate amount of iodine was added as a solid. The solvent was removed under vacuum and the product was 
purified on a short silica gel column using CH2Cl2/hexane/triethylamine (100:300:2) as eluent and recrystallised from 
CH2Cl2/MeOH. 
5-Iodo-10,20-diphenylporphyrin (3) from bromoporphyrin (2) 
Bromoporphyrin 2 (10 mg, 0.018 mmol), Pd2dba3 (22 mg, 0.024 mmol) and PPh3 (25 mg, 0.095 mmol) gave after 
stirring in 5 ml toluene at 105° C for 2 h, addition of toluene (1.25 ml) and iodine (6.4 mg, 0.025 mmol), the desired 
product as a dark purple crystalline powder (8.5 mg, 78%). 
5-Iodo-10,15,20-triphenylporphyrin (9) 
Bromoporphyrin 5 (25 mg, 0.040 mmol), Pd2dba3 (37 mg, 0.041 mmol) and PPh3 (43 mg, 0.164 mmol) gave after 
stirring in 10 ml toluene at 105° C for 2 h, addition of toluene (7 ml) and iodine (20 mg, 0.079 mmol), the desired 
product as a dark purple crystalline powder (21 mg, 79%). The NMR data agreed with those of an authentic sample 
previously prepared by our group [3b]. 
5-Iodo-10,20-bis(3’,5’-di-tert-butylphenyl)-15-phenylporphyrin (10) 
Bromoporphyrin 6 (25 mg, 0.030 mmol), Pd2dba3 (28 mg, 0.031 mmol) and PPh3 (32 mg, 0.122 mmol) gave after 
stirring in 15 ml toluene at 105° C for 2.5 h, addition of toluene (10 ml) and iodine (19 mg, 0.075 mmol), the desired 
product as a dark purple crystalline powder (21 mg, 75%). 1H NMR (400 MHz, CDCl3, 25° C): ™H, ppm 9.68, 8.91, 
8.82, 8.80 (d, each 2H, J 4.6 Hz, β-H), 8.22-8.18 (m, 2H, o-H on 15-phenyl), 8.05 (d, 4H, J 1.7 Hz, 2,6-H on 5,15-
aryl), 7.82 (t, 2H, J 1.7 Hz, 4-H on 5,15-aryl), 7.77-7.71 (m, 3H, m,p-H on 15-phenyl), 1.56 (s, 36H, t-butyl), -3.01 (br 
s, 2H, NH). UV-vis (CH2Cl2): ⎣max, nm (∑, 103 M-1.cm-1) 423 (311), 522 (14.6), 557 (8.3), 597 (4.7), 654 (4.4). High-
resolution ESI MS: m/z 889.3705 ([C54H57IN4+H]+ requires 889.3706). Anal. calcd., %: C, 72.96; H, 6.46; N, 6.30. 
Found: C, 73.34; H, 6.43; N, 6.00. 
5-Bromo-15-iodo-10,20-diphenylporphyrin (11) 
Dibromoporphyrin 7 (31 mg, 0.050 mmol) and Pd(PPh3)4 (60 mg, 0.052 mmol) gave after stirring in 30 ml toluene 
at 105° C for 5 h, addition of toluene (30 ml) and iodine (63 mg, 0.248 mmol), the desired product as a dark purple 
crystalline powder (26 mg, 78%). The NMR data agreed with those in the literature [8h]. 
5-Bromo-15-iodo-10,20-bis(3’,5’-di-tert-butyl)phenylporphyrin (12) 
Dibromoporphyrin 8 (42 mg, 0.050 mmol) and Pd(PPh3)4 (58 mg, 0.050 mmol) gave after stirring in 30 ml toluene 
at 105° C for 4h, addition of toluene (30 ml) and iodine (64 mg, 0.252 mmol), the desired product as a dark purple 
crystalline powder (36 mg, 81%). 1H NMR (400 MHz, CDCl3, 25° C): ™H, ppm 9.64-9.61 (m, 4H, β-H), 8.88-8.83 (m, 
4H, β-H), 8.02 (d, 4H, J 1.9 Hz, 2,6-H on 10,20-aryl), 7.83 (t, 2H, J 1.8 Hz, 4-H on 10,20-aryl), 1.55 (s, 36H, t-butyl), -
2.63 (br s, 2H, NH). UV-vis (CH2Cl2): ⎣max, nm (∑, 103 M-1.cm-1) 425 (252), 524 (10.8), 560 (8.7), 604 (3.1), 661 (4.3). 
High-resolution ESI MS: m/z 891.2492 ([C48H52BrIN4+H]+ requires 891.2498). Anal. calcd., %: C, 64.65; H, 5.88; N, 
6.28. Found: C, 64.63; H, 5.91; N 5.98. 
[10,20-Bis(3’,5’-di-tert-butylphenyl)-15-phenylporphyrin-5-yl]diphenylphosphine oxide (13) 
Iodoporphyrin 10 (10 mg, 0.0112 mmol) and (CH3CN)2PdCl2 (0.3 mg, 0.0012 mmol) were dried under high vacuum 
in a Schlenk vessel which was subsequently charged with argon. After the addition of toluene (1 ml), the reaction 
mixture was heated to 80º C, before adding diphenyl(trimethylsilyl)phosphine (6 ⎧L, 0.0235 mmol) by syringe. The 
solvent was removed under vacuum after 72 h, and the residue purified on a silica gel column using 
CHCl3/triethylamine (200:1) as eluent. The major less polar fraction was identified as a mixture of iodoporphyrin 10 
and [10,20-bis(3’,5’-di-tert-butylphenyl)-15-phenylporphyrin. After changing the eluent to a mixture of 
CHCl3/MeOH/triethylamine 196:4:1) the crude target compound was collected. This product was dissolved 
successively in a series of solvents (MeOH, diethyl ether, CHCl3, pentane) every time filtering off unwanted solids, 
then recovering by evaporation. The porphyrinylphosphine oxide 13 was finally isolated as dark red powder (2.2 mg, 
20%). The desired target compound can also be isolated under similar reaction conditions in only 2% yield if starting 
from bromoporphyrin 6.1H NMR (400 MHz, CDCl3, 25° C): ™H, ppm 9.42 (br d, 2H, J 4.7 Hz, β-H), 8.77, 8.71, 8.63 
(d, each 2H, J 4.7 Hz, β-H), 8.19-8.17 (m, 2H, o-H on 15-phenyl), 7.97 (d, 4H, J 1.7 Hz, 2,6-H on 10,20-aryl), 7.95-
7.90 (m, 4H, o-H PPh2), 7.76 (t, 2H, J 1.7 Hz, 4-H on 10,20-aryl), 7.77-7.70 (m, 3H, m,p-H 15-phenyl), 7.55-7.50 (m, 
2H, p-H PPh2), 7.45-7.40 (m, 4H, m-H PPh2), 1.49 (s, 36H, t-butyl), -2.04 (br s, 2H, NH); 31P NMR (162 MHz, CDCl3, 
25° C): ™P, ppm 34.6. UV-vis (CH2Cl2): ⎣max, nm (∑, 103 M-1.cm-1) 423 (217), 521 (10.2), 557 (6.1), 592 (3.8), 649 
(3.5). High-resolution ESI MS: m/z 963.5141 ([C66H67N4OP+H]+ requires 963.5131). 
(E)-5-(2-Bromoethenyl)-10,15,20-triphenylporphyrin (15) 
Porphyrin 14 (150 mg, 0.27 mmol) and pyridinium tribromide (91 mg, 0.28 mmol) were added to a 50 ml flask, 
dissolved in THF (20 ml) and allowed to stir at room temperature overnight. The solution turned bright green, due to 
protonation of the free-base porphyrin. After 14 h, triethylamine (1 ml) was added, changing the colour of the solution 
to purple. The solvent was removed under vacuum and the residue was then loaded onto a plug of silica gel using 
CH2Cl2/hexane/triethylamine (100:100:1) as eluent. The porphyrin band was collected and the residue recrystallised 
from CH2Cl2/MeOH to give the product as a purple crystalline powder (141 mg; 81%). 1H NMR (400 MHz, CDCl3, 
25° C): ™H, ppm 9.61 (d, 1 H, J 13.9 Hz, alkene-H), 9.43, 8.95 (d, each 2 H, J 4.9 Hz, β-H), 8.83 (br s, 4 H, β-H), 8.22 
(m, 2 H, o-H ), 7.79 (m, 9 H, m, p-H), 7.10 (d, 1 H, J 13.9 Hz, alkene-H), -2.70 (br s, 2 H, NH). UV-vis (CH2Cl2): ⎣max, 
nm (∑, 103 M-1.cm-1) 420 (151), 520 (7.2), 555 (4.4), 594 (1.6), 651 (1.2). LDI MS: m/z 642.14 ([C40H27BrN4]+ requires 
642.14). Anal. calcd., %: C, 74.65; H, 4.23; N, 8.71; Found C, 74.71; H, 4.17; N, 8.56. 
(E)-5-(2-Iodoethenyl)-10,15,20-triphenylporphyrin (16) 
Bromoethenylporphyrin 15 (50 mg, 0.078 mmol) was dissolved in dry toluene (10 ml) in a Schlenk vessel. The 
solvent was deoxygenated by freeze/thawing three times and purged with argon. Freshly prepared Pd(PPh3)4 (100 mg, 
0.087 mmol) was added and the reaction mixture was allowed to stir for 1.5 hours at room temperature. Iodine (50 mg, 
0.20 mmol), triethylamine (25 μL, 0.2 mmol) and toluene (10 ml) were added and the reaction was allowed to stir for 
14 hours overnight, open to air. The reaction was transferred to a separating funnel and washed with Na2S2O3 solution 
(1 M, 50 ml x 3) and dried over Na2SO4. The solvent was removed under vacuum and the residue was purified on a 
silica gel column using CH2Cl2/hexane/triethylamine (300:100:2) as eluent. The porphyrin band was collected, dried 
and recrystallised to give a purple crystalline powder (50 mg, 93%). 1H NMR (400 MHz, CDCl3, 25° C): ™H, ppm 9.92 
(d, 1 H, J 14.7 Hz, alkene-H), 9.39, 8.92 (d, each 2 H, J 4.9 Hz, β-H), 8.81 (br s, 4 H, β-H), 8.18 (m, 2 H, o-H), 8.20 
(m, 9 H, m,p-H), 7.19 (d, 1 H, J 14.7 Hz, alkene-H), -2.70 (br s, 2 H, NH); UV-vis (CH2Cl2): ⎣max, nm (∑, 103 M-1.cm-1) 
422 (151), 519 (7.6), 557( 4.9), 595 (3.0), 651 (2.6). LDI MS: m/z 691.14 ([C40H27IN4+H]+ requires 691.14). 
(E)-5-(2-Iodoethenyl)-10,15,20-triphenyporphyrinatonickel(II) (17) 
Free base iodoethenylporphyrin 16 (50 mg, 0.066 mmol) and Ni(acac)2 (18 mg, 0.071 mmol) were added to a 50 ml 
flask, dissolved in toluene (10 ml) and brought to reflux. The progress of the reaction was monitored by TLC using 
CH2Cl2/hexane (1:1) as eluent, which indicated after 3 h that the starting porphyrin was consumed. The solvent was 
removed under vacuum and the product was isolated after passage through a plug of silica gel using CHCl3 as the 
eluent. Recrystallisation of the product from CHCl3/MeOH yielded the product as a red crystalline powder (109 mg, 
99%). 1H NMR (400 MHz, CDCl3, 25° C): ™H, ppm 9.61 (d, 1 H, J 14.7 Hz, alkene-H), 9.25, 8.81, 8.69, 8.66 (d, each 
2 H, J 4.9 Hz, β-H), 7.98 (m, 2 H, o-H), 7.68 (m, 9 H, m,p-H), 6.71 (d, 1 H, J 14.7 Hz, alkene-H). UV-vis (CH2Cl2): 
⎣max, nm (∑, 103 M-1.cm-1) 419 (145), 535 (11.2), 571 (4.2). LDI MS: m/z 769.04 ([C40H25IN4Ni+Na]+ requires 769.04). 
(E)-5-(2-Iodoethenyl)-10,15,20-triphenylporphyrinatozinc(II) (18) 
Free base iodoethenylporphyrin 16 (20 mg, 0.029 mmol) was dissolved in CHCl3 (5 ml) and brought to reflux. 
Zinc(II) acetate (20 mg, 0.1 mmol) was dissolved in MeOH (0.5 ml) and added dropwise through the condenser to the 
refluxing mixture. The progress of the reaction was monitored by TLC using CHCl3/hexane (1:1) as eluent. The heat 
source was removed after 15 minutes and the solution was allowed to cool. The solvents were removed under vacuum 
and the product was isolated after passage through a plug of silica gel using CHCl3 as the eluent. Recrystallisation of 
the purple residue using CHCl3(1% pyridine)/MeOH yielded the product as a bright purple crystalline powder (21 mg, 
90%). 1H NMR (400 MHz, CDCl3 + 1% d5 pyridine, 25° C): ™H, ppm 10.00 (d, 1 H, J 14.7 Hz, alkene-H), 9.42, 8.93 
(d, each 2 H, J 4.6 Hz, β-H), 8.81 (br s, 4 H, β-H), 8.17 (m, 6 H, o-H), 7.8 (m, 9 H, m,p-H), 7.05 (d, 1 H, J 14.7 Hz, 
alkene-H). UV-vis (CH2Cl2): ⎣max, nm (∑, 103 M-1.cm-1) 425 (151), 555 (9.1), 608 (4.8). High-resolution ESI MS: m/z 
775.0304 ([C40H25IN4Zn+Na]+ requires 775.0313). 
X-Ray single crystal structure determination of 5-iodo-10,20-diphenylporphyrin (3) 
The crystals were obtained by recrystallising the product from CHCl3/MeOH. Growth and handling of crystals 
followed the concept developed by Hope [17]. Intensity data were collected at 90 K with a Bruker SMART Apex2 
system complete with 3-circle goniometer and CCD detector utilizing Mo-Kα radiation (λ = 0.71073 Å). The intensities 
were corrected for Lorentz, polarization, absorption and extinction effects. The structure was solved with Direct 
Methods using the SHELXTL PLUS program system [18] and refined against |F2| with the program XL from SHELX-
97 using all data [19]. Nonhydrogen atoms were refined with anisotropic thermal parameters. Hydrogen atoms were 
generally placed into geometrically calculated positions and refined using a riding model. Residual electron density was 
located in the middle of the porphyrin ring system indicating the presence of a metalloporphyrin impurity. Refinement 
with a free variable of occupancy as a palladium atom gave an occupancy of 0.014. Due to the small amount of 
metalloporphyrin present this peak was not included in the final refinement. CCDC-605794 contains the supplementary 
crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  
Crystal data: C32H21IN4. FW = 588.43, black parallelpiped, crystal size 0.3 x 0.08 x 0.01 mm, monoclinic, P21/c, a = 
13.349(3) Å, b = 18.981(4) Å, c = 9.841(2) Å, β = 104.87(3)°, V = 2410.0(10) Å3, Z = 4, dcalcd = 1.622 Mg.m-3, μ(Mo 
Kα) = 1.359 mm-1, Tmin = 0.92, Tmax = 0.99, θmax = 31.53°, 20390 reflections collected, 7981 independent reflections, 
Rint = 0.0235, 6844 reflections with I > 2.0σ(I), 334 parameters, R1 (I > 2.0σ(I)) = 0.0291, R1 (all data) = 0.0364, wR2 
(all data) = 0.0782, S = 1.024, ρmax = 2.902 e.Å-3. 
RESULTS AND DISCUSSION 
The oxidative addition of molecular I2 to organoplatinum(II) complexes to yield Pt(IV) complexes is well 
documented in the literature [20]. On the other hand the same reaction with organopalladium(II) complexes is very 
rarely investigated, presumably because the resulting Pd(IV) complexes are very unstable. Only two examples of 
Pd(IV) complexes resulting from the oxidative addition of I2 to a Pd(II) complex have been reported so far and in both 
examples, these compounds were only detected by NMR and could not be isolated in the solid state [21]. There are 
however some reports describing the iodination of an organic fragment resulting from the organopalladium(II) 
intermediate [21b,22]. Although none of these reports investigates a halogen exchange of an organic species, we 
decided to pursue this avenue in order to achieve the meso-iodination of porphyrins. 
In our first experiment, isolated η1-palladioporphyrin 1, which can be prepared from the reaction of 5-bromo-10,20-
diphenylporphyrin (H2DPPBr, 2) with Pd2dba3 (dba = dibenzylideneacetone) and dppe (dppe = 1,2-
bis(diphenylphosphino)ethane) [2], was reacted with I2 (Scheme 1).  
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Scheme 1. Iodination of η1-palladioporphyrin 
The reaction was carried out at room temperature under aerobic conditions and was complete in 10 minutes to give 
the desired iodoporphyrin in 91% yield. The purification was achieved on a short silica gel column using a mixture of 
CH2Cl2 and hexane as eluent. After collecting the porphyrin fraction, by-product palladium(II) complexes 4 were eluted 
using CH2Cl2. 
Encouraged by this result, we decided to carry out the halogen exchange reaction in situ starting from 
bromoporphyrins, omitting the isolation of the η1-palladioporphyrin intermediates. A variety of meso-iodoporphyrins 
can be isolated by this method in excellent yields (Scheme 2). 
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Scheme 2. One-pot meso-iodination 
The oxidative addition of the Pd(0) fragment is best carried out under an atmosphere of argon at 105° C. After the 
total consumption of the starting bromoporphyrin the argon atmosphere is not necessary. The reaction mixture should 
be diluted and cooled to room temperature before the addition of iodine, in order to avoid the formation of insoluble 
materials, whose nature is presently unknown. The slightly lower yields of these reactions in comparison to the 
iodination of η1-palladioporphyrin 1 can be explained by the expected partial dehalogenation of the bromoporphyrins 
[3a]. In the case of dibromoporphyrins 7 and 8, we used freshly prepared Pd(PPh3)4 as the source of Pd(0) in order to 
control the rate and hence selectivity of the reaction. As the addition of only one molar equivalent of Pd(0) was desired, 
these reactions were also carried out in dilute solutions. The clean formation of the 5-η1-palladio(II)-15-bromo-10,20-
diarylporphyrins was initially monitored by 1H-NMR of the reaction mixtures and the results agreed well with the data 
for the isolated compounds [5]. In order to achieve the iodination, solid I2 pieces were added to the reaction mixtures. 
The slow solubility of I2 in toluene at room temperature ensures that no insoluble materials are formed. The products 
can be easily purified on a short silica gel column and the dihalobis(phosphine) Pd(II) by-products can also be 
recovered in the cases where Pd(PPh3)4 is utilised. Again the only observed side products were the mono-
dehalogenated porphyrins, i.e. 5-bromo-10,20-diarylporphyrins. The overall yields and short reaction times for the 
formation of mixed haloporphyrins 11 and 12 suggest this is an improvement to the reported method for the preparation 
of 7 [8h], as the yield limiting monobromination of the 5,15-diarylporphyrins is not necessary and the iodination can be 
carried out in 4-5 h instead of the previously reported 48 h. Moreover, the palladium could, in principle, be recycled, as 
any dihalobis(triphenylphosphine) palladium(II) complex (or mixed complexes) can be reduced in the presence of 
excess triphenylphosphine to Pd(PPh3)4 [16]. 
Our initial reason for the development of this iodination method was the unsuccessful palladium catalysed 
phosphination of porphyrins (Scheme 3). 
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Scheme 3. Palladium catalysed phosphination 
Due apparently to the less reactive C-Br bond, bromoporphyrin 6 yielded the phosphine oxide in a very poor yield of 
only 2 % after 72 hours at 80° C. Use of iodoporphyrin 10 on the other hand resulted in the formation of 
porphyrinylphosphine oxide 13 in 20 % yield under the same reaction conditions. The desired tertiary phosphine itself 
is extremely easily oxidised and only the oxide has been isolated from these reactions. Prolonged reaction times and 
temperatures above 85° C lead only to the decomposition of the target compound. The successful generation of a suite 
of porphyrinylphosphine oxides by a different palladium catalysed route will be reported elsewhere [23]. 
Another reason for the development of this halogen exchange methodology is our interest in the palladium catalysed 
formation of meso-meso ethene-linked porphyrin dyads. As seen in our previous studies of the Heck alkenation 
reaction, the desired coupling does not occur with 5-ethenyl-10,15,20-triphenylporphyrin 14 and bromoporphyrins, but 
Ni(II) analogues result in novel meso-β ethene-linked bisporphyrins. Consequently, we tried a different methodology 
for the synthesis of the meso-meso linked dyads, namely Suzuki coupling [15]. For this route, (2-
haloethenyl)porphyrins are potential synthons for the formation of these dyads. Ni(II) 
bromoethenyloctaethylporphyrins were first synthesised by Arnold et al. from the parent ethenylporphyrin and 
pyridinium tribromide [24]. Later, this methodology was adapted by Shi et al. for free-base porphyrins [25]. Using the 
same brominating reagent in a THF solution at room temperature overnight with ethenylporphyrin 14, the 
bromoethenylporphyrin 15 was synthesised as the sole isomer and in good yield (81%). Interestingly, attempts at 
coupling 15 with porphyrinyl boronates were unsuccessful [26]. Thus a method for the formation of 
iodoethenylporphyrins was developed (Scheme 4).  
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Scheme 4. Formation of iodoethenylporphyrins; conditions: i) pyridinium tribromide; ii) 1. Pd(PPh3)4, 2. I2; iii) Ni(acac)2; iv) 
Zn(OAc)2 
Ni(II) iodoethenyloctaethyl- and tetraphenylporphyrins have been previously synthesised by Arnold and Hartnell 
using the CrCl2 promoted Takai iodoalkenation [12], however, other metallated and free-base analogues have not been 
reported. This reaction is unsuitable for free base porphyrins due to the use of the transition metal salt. The reaction 
conditions we normally use for inserting Pd(0) into meso-bromoporphyrins proved too vigorous for insertion into 15, 
the result being decomposition of the starting material into multiple products that have not yet been characterised. 
Presumably this result is due to the alkenyl-Pd bond being more labile than a Pd-porphyrin direct bond. The insertion of 
Pd(0) onto arylalkenyl bromides at 0°C was reported by Loar and Stille [27]. Inserting Pd(0) into 15 at room 
temperature, followed by the addition of I2 in a one-pot procedure, led to the desired free-base iodoethenylporphyrin in 
very good yield. Fortunately, the high reactivity of the alkene-Br bond allows a high yield to be obtained under very 
mild conditions. The palladium catalysed formation of meso-meso ethene-linked diporphyrins from 
iodoethenylporphyrins 16, 17 and 18 and various porphyrinyl boronates will be reported elsewhere [26]. 
 
The X-ray structure of 3 is shown in Fig. 1. The compound crystallized in the monoclinic space group P21/c and 
overall shows the typical structural features for a meso-substituted porphyrin of the A2B–type [28]. Only very few 
crystal structures of this type have been reported [29]. A related structure is the planar Ni(II) complex of the related 5-
bromoporphyrin [30]. The macrocycle exhibits a moderate degree of nonplanarity with an overall Δ24 (deviation of the 
24 macrocycle atoms from their least-squares-plane) of 0.078 Å. The conformation is characterized by out-of-plane 
deformations with contributions from sad, ruf, and wav(x) distortion modes [31]. Additionally, minor contributions 
from in-plane distortions are present. The largest deviations are observed for the β-positions C2 (0.17 Å) and C3 (0.24 
Å), i.e. the pyrrole ring neighboured both by the meso-iodo and a meso-phenyl substituent. The C5-I1 bond is of typical 
length [2.119(2) Å] and the iodinated meso-quadrant shows a widending of the Ca-Cm-Ca bond angle [128.42(16)°] 
compared to the two meso-phenyl quadrants [average Ca-Cm-Ca bond angle 123.85(17)°]. The unsubstituted C15 
quadrant also exhibits a widened Ca-Cm-Ca bond angle [127.60(17)°], indicating the presence of in-plane distortion 
modes as a result of the bulky iodine residue. 
 
Figure 1. View of the molecular structure of 3 in the crystal. Thermal ellipsoids are drawn for 50% occupancy and hydrogen atoms 
have been omitted for clarity. 
 
In summary, we have developed a rapid, selective and high yielding methodology for the convenient one-pot meso-
iodination of various 5,15-diaryl- and 5,10,15-triarylporphyrins from bromoporphyrins via η1-palladioporphyrin 
intermediates. Due to the mild reaction conditions, we propose that this method is applicable to any diarylporphyrin. 
This sequence is also very convenient for converting meso-(2-bromoethenyl)porphyrins to their iodoethenyl analogues. 
Subsequent use of the iodo starting materials has confirmed their utility in palladium catalysed couplings to form novel 
substituted porphyrins and diporphyrins. 
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